Articles From: Actavis Prices $21 Billion Bond--Update to Active Power to Present at the 27th Annual ROTH Conference on March 10, 2015


2015/3/3
By Mike Cherney Actavis PLC sold $21 billion in bonds on Tuesday and lowered the yields on the deal, reflecting strong investor demand for a bond that ranks as the second-largest corporate offering on record.
Sign-up for Actavis Prices $21 Billion Bond--Update investment picks
2015/3/1
By Mike Cherney Pharmaceutical company Actavis PLC is expected to sell more than $20 billion in bonds as early as this week, a deal that would rank as the second-largest corporate bond ever and further propel bond sales this year into record territory.
Sign-up for Actavis Readies Big Bond Deal investment picks
2015/3/2
- Treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Adults - - New Treatment's Unique Dosage Regimen Offers a New Approach to the Treatment of ABSSSI - DUBLIN , March 2, 2015 /PRNewswire/ --
Sign-up for Actavis Receives Approval from the European Commission for XYDALBA™ (dalbavancin) investment picks
2015/2/20
DUBLIN , Feb.
Sign-up for Actavis Receives Final Approval for Generic Version of Subutex® investment picks
2015/2/25
- Treatment for Adult Patients with Complicated Intra-abdominal infections (cIAI) and Complicated Urinary Tract Infections (cUTI) - - New Treatment Addresses Serious Infections in Patients Who Have Limited or No Alternative Treatment Options - DUBLIN , Feb.
Sign-up for Actavis Receives U.S. FDA Approval for AVYCAZ™ (CEFTAZIDIME-AVIBACTAM) investment picks
2015/1/26
Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) today announced that the U.S. Securities and Exchange Commission has declared effective Actavis’ registration statement on Form S-4 relating to Actavis’ pending acquisition of Allergan.
Sign-up for Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC investment picks
2015/1/26
- Meeting Dates for Actavis and Allergan Shareholder Meetings Set for March 10, 2015 - DUBLIN and IRVINE, Calif.
Sign-up for Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC investment picks
2015/3/2
By Mike Cherney Would rank as second-largest ever Pharmaceutical company Actavis PLC is expected to sell more than $20 billion in bonds as early as this week, a deal that would rank as the second-largest corporate bond ever and further propel bond sales this year into record territory.
Sign-up for Actavis set for $20 billion corporate-bond sale investment picks
2015/1/26
- Vaults Actavis to #1 Position in UK Generics - - Immediately Accretive to Non-GAAP Earnings - - Adds ~175 Marketed Products; Pipeline of ~40 Products - DUBLIN and LONDON , Jan.
Sign-up for Actavis to Acquire Auden Mckenzie for 306M GBP investment picks
2015/2/9
DUBLIN , Feb.
Sign-up for Actavis to Divest Doryx® to Mayne Pharma investment picks
2015/2/9
By Maria Armental and Robb M.
Sign-up for Actavis to Divest Itself of U.S. Doryx Rights Ahead of Allergan Deal -- Update investment picks
2015/2/13
-- TPG to Focus Company on Growth and Development of Innovative Products --
Sign-up for Actavis to Divest Pharmatech to TPG investment picks
2015/2/5
- Divestiture permits Actavis to enhance focus on core strategic therapeutic categories - DUBLIN , Feb.
Sign-up for Actavis to Divest Rights to Branded Respiratory Portfolio in the U.S. and Canada to AstraZeneca investment picks
2015/2/9
Actavis PLC (ACT) will sell the U.S. rights to an acne treatment as it seeks to refine its dermatology portfolio ahead of its purchase of Botox maker Allergan Inc. The Doryx deal, valued at about $50 million and expected to close by month's end, follows last week's announcement that AstraZeneca PLC (AZN) was buying Actavis" branded respiratory business in the U.S. and Canada for an initial $600 million.
Sign-up for Actavis to Divest U.S. Doryx Rights Before Allergan Deal investment picks
2014/12/22
DUBLIN , Dec.
Sign-up for Actavis to Present at 33rd Annual J.P. Morgan Healthcare Conference investment picks
2014/12/19
DUBLIN , Dec.
Sign-up for Actavis to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference investment picks
2015/2/19
By Angela Chen Actavis PLC said Thursday that it plans to sell $8.4 billion in shares to fund its planned acquisition of Allergan Inc. Shares were down about 2.8% to $277 in premarket trading.
Sign-up for Actavis to Sell $8.4 Billion in Shares to Fund Allergan Acquisition investment picks
2015/3/2
By Mike Cherney Actavis PLC plans to complete a bond offering this week of more than $20 billion in size, the latest sign of a booming bond market and a deal which would rank as the second-largest corporate offering on record.
Sign-up for Actavis to Tap Bond Market This Week With Mega Deal investment picks
2015/3/2
By Mike Cherney Actavis PLC plans to complete its more-than-$20-billion bond offering on Tuesday, the latest sign of a booming bond market and a deal which would rank as the second-largest corporate offering on record.
Sign-up for Actavis to Wrap Up Mega-Bond Sale on Tuesday investment picks
2014/12/15
DUBLIN , Dec.
Sign-up for Actavis Will Appeal Injunction Requiring Continued Distribution of NAMENDA® IR investment picks
2015/2/27
Actavis Inc. (ACT) said Friday it has received regulatory approval for a new intrauterine birth-control device that prevents pregnancy for up to three years.
Sign-up for Actavis, partner develop three-year IUD investment picks
2015/1/6
ZHUHAI, China , Jan.
Sign-up for Actions Launches Single-Chip Bluetooth 4.0 Multimedia Solution investment picks
2015/2/3
ZHUHAI, China , Feb.
Sign-up for Actions Semiconductor Reports Fourth Quarter and Full Year 2014 Results investment picks
2015/1/20
ZHUHAI, China , Jan.
Sign-up for Actions Semiconductor to Report Fourth Quarter and Fiscal Year 2014 Financial Results on February 3, 2015 investment picks
2015/1/5
ZHUHAI, China , Jan.
Sign-up for Actions to Debut First 64-bit Chipset at the 2015 International CES investment picks
2014/12/15
ZHUHAI, China , Dec.
Sign-up for Actions to Showcase Tablet and Bluetooth Boombox Solutions at the 2015 International CES investment picks
2015/2/18
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1176087&ProfileId=051205&sourceType=1 BELLINGHAM, WA --
Sign-up for ActionSprout Joins Blackbaud Partner Network as a Blackbaud Technology Partner investment picks
2015/2/17
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1175605&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for Active Power Appoints Peter Gross to Board of Directors investment picks
2015/2/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1174221&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for Active Power Sets Fourth Quarter and Full Year 2014 Conference Call for February 24 at 8:30 a.m. ET investment picks
2015/2/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1177858&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for Active Power to Present at the 27th Annual ROTH Conference on March 10, 2015 investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Actavis Prices $21 Billion Bond--Update to Active Power to Present at the 27th Annual ROTH Conference on March 10, 2015
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent